Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
569.5 DKK | +0.62% | -3.47% | +22.79% |
Apr. 22 | U.S. Futures, European Stocks Rise | DJ |
Apr. 16 | GRI Bio Receives South Korea Patent for Liver Inflammatory Condition Treatments | MT |
Sales 2024 * | 22.01B 3.16B | Sales 2025 * | 22.96B 3.29B | Capitalization | 30.36B 4.35B |
---|---|---|---|---|---|
Net income 2024 * | 1.28B 183M | Net income 2025 * | 1.34B 193M | EV / Sales 2024 * | 1.16 x |
Net cash position 2024 * | 4.82B 691M | Net cash position 2025 * | 3.75B 537M | EV / Sales 2025 * | 1.16 x |
P/E ratio 2024 * |
23.8
x | P/E ratio 2025 * |
22.6
x | Employees | 4,449 |
Yield 2024 * |
-
| Yield 2025 * |
0.63% | Free-Float | 99.68% |
Latest transcript on NKT A/S
1 day | +1.10% | ||
1 week | -3.56% | ||
Current month | -0.18% | ||
1 month | -3.97% | ||
3 months | +18.69% | ||
6 months | +66.67% | ||
Current year | +22.68% |
Managers | Title | Age | Since |
---|---|---|---|
Claes Westerlind
CEO | Chief Executive Officer | 42 | 16-12-31 |
Michael Hjorth
CEO | Chief Executive Officer | 58 | 04-12-31 |
Line Fandrup
DFI | Director of Finance/CFO | 44 | 20-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jens Due Olsen
CHM | Chairman | 60 | 05-12-31 |
Director/Board Member | 69 | 15-12-31 | |
Andreas Nauen
BRD | Director/Board Member | 59 | 16-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 773 M€ | -.--% | - | |
0.02% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 569.5 | +0.62% | 119 517 |
24-04-23 | 566 | -0.70% | 126,010 |
24-04-22 | 570 | -4.20% | 246,731 |
24-04-19 | 595 | -0.50% | 135,154 |
24-04-18 | 598 | +1.36% | 80,615 |
Delayed Quote Nasdaq Copenhagen, April 24, 2024 at 03:42 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.68% | 4.35B | |
+3.04% | 147B | |
+29.91% | 125B | |
+15.41% | 125B | |
+12.78% | 62.76B | |
+9.07% | 41.58B | |
-11.00% | 31.67B | |
+2.93% | 30.92B | |
+64.79% | 30.24B | |
+2.55% | 26.99B |
- Stock Market
- Equities
- NKT Stock